| Year |
Citation |
Score |
| 2020 |
Bessou M, Lopez J, Gadet R, Deygas M, Popgeorgiev N, Poncet D, Nougarède A, Billard P, Mikaelian I, Gonzalo P, Rimokh R, Gillet G. The apoptosis inhibitor Bcl-xL controls breast cancer cell migration through mitochondria-dependent reactive oxygen species production. Oncogene. PMID 32066881 DOI: 10.1038/S41388-020-1212-9 |
0.535 |
|
| 2019 |
Grandin N, Pereira B, Cohen C, Billard P, Dehais C, Carpentier C, Idbaih A, Bielle F, Ducray F, Figarella-Branger D, Delattre JY, Sanson M, Lomonte P, Poncet D, Verrelle P, et al. The level of activity of the alternative lengthening of telomeres correlates with patient age in IDH-mutant ATRX-loss-of-expression anaplastic astrocytomas. Acta Neuropathologica Communications. 7: 175. PMID 31706351 DOI: 10.1186/S40478-019-0833-0 |
0.319 |
|
| 2013 |
Biroccio A, Cherfils-Vicini J, Augereau A, Pinte S, Bauwens S, Ye J, Simonet T, Horard B, Jamet K, Cervera L, Mendez-Bermudez A, Poncet D, Grataroli R, de Rodenbeeke CT, Salvati E, et al. TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells. Nature Cell Biology. 15: 818-28. PMID 23792691 DOI: 10.1038/Ncb2774 |
0.356 |
|
| 2008 |
Bionda C, Athias A, Poncet D, Alphonse G, Guezguez A, Gambert P, Rodriguez-Lafrasse C, Ardail D. Differential regulation of cell death in head and neck cell carcinoma through alteration of cholesterol levels in lipid rafts microdomains. Biochemical Pharmacology. 75: 761-72. PMID 17996216 DOI: 10.1016/J.Bcp.2007.10.004 |
0.453 |
|
| 2007 |
Deniaud A, Sharaf el dein O, Maillier E, Poncet D, Kroemer G, Lemaire C, Brenner C. Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis. Oncogene. 27: 285-99. PMID 17700538 DOI: 10.1038/Sj.Onc.1210638 |
0.607 |
|
| 2007 |
Pauleau AL, Larochette N, Giordanetto F, Scholz SR, Poncet D, Zamzami N, Goldmacher VS, Kroemer G. Structure-function analysis of the interaction between Bax and the cytomegalovirus-encoded protein vMIA. Oncogene. 26: 7067-80. PMID 17496930 DOI: 10.1038/Sj.Onc.1210511 |
0.714 |
|
| 2006 |
Poncet D, Pauleau AL, Szabadkai G, Vozza A, Scholz SR, Le Bras M, Brière JJ, Jalil A, Le Moigne R, Brenner C, Hahn G, Wittig I, Schägger H, Lemaire C, Bianchi K, et al. Cytopathic effects of the cytomegalovirus-encoded apoptosis inhibitory protein vMIA. The Journal of Cell Biology. 174: 985-96. PMID 16982800 DOI: 10.1083/Jcb.200604069 |
0.767 |
|
| 2004 |
Boya P, Pauleau AL, Poncet D, Gonzalez-Polo RA, Zamzami N, Kroemer G. Viral proteins targeting mitochondria: controlling cell death. Biochimica Et Biophysica Acta. 1659: 178-89. PMID 15576050 DOI: 10.1016/J.Bbabio.2004.08.007 |
0.732 |
|
| 2004 |
Arnoult D, Bartle LM, Skaletskaya A, Poncet D, Zamzami N, Park PU, Sharpe J, Youle RJ, Goldmacher VS. Cytomegalovirus cell death suppressor vMIA blocks Bax- but not Bak-mediated apoptosis by binding and sequestering Bax at mitochondria. Proceedings of the National Academy of Sciences of the United States of America. 101: 7988-93. PMID 15148411 DOI: 10.1073/Pnas.0401897101 |
0.776 |
|
| 2004 |
Poncet D, Larochette N, Pauleau AL, Boya P, Jalil AA, Cartron PF, Vallette F, Schnebelen C, Bartle LM, Skaletskaya A, Boutolleau D, Martinou JC, Goldmacher VS, Kroemer G, Zamzami N. An anti-apoptotic viral protein that recruits Bax to mitochondria. The Journal of Biological Chemistry. 279: 22605-14. PMID 15004026 DOI: 10.1074/Jbc.M308408200 |
0.75 |
|
| 2004 |
Poncet D, Boya P, Métivier D, Zamzami N, Kroemer G. Cytofluorometric quantitation of apoptosis-driven inner mitochondrial membrane permeabilization. Apoptosis : An International Journal On Programmed Cell Death. 8: 521-30. PMID 14601558 DOI: 10.1023/A:1025546525894 |
0.77 |
|
| 2003 |
Boya P, Gonzalez-Polo RA, Poncet D, Andreau K, Vieira HL, Roumier T, Perfettini JL, Kroemer G. Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. Oncogene. 22: 3927-36. PMID 12813466 DOI: 10.1038/Sj.Onc.1206622 |
0.794 |
|
| 2003 |
Boya P, Andreau K, Poncet D, Zamzami N, Perfettini JL, Metivier D, Ojcius DM, Jäättelä M, Kroemer G. Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion Journal of Experimental Medicine. 197: 1323-1334. PMID 12756268 DOI: 10.1084/Jem.20021952 |
0.764 |
|
| 2003 |
Haouzi D, Cohen I, Vieira HL, Poncet D, Boya P, Castedo M, Vadrot N, Belzacq AS, Fau D, Brenner C, Feldmann G, Kroemer G. Mitochondrial permeability transition as a novel principle of hepatorenal toxicity in vivo. Apoptosis : An International Journal On Programmed Cell Death. 7: 395-405. PMID 12207172 DOI: 10.1023/A:1020026923038 |
0.618 |
|
| 2002 |
Debatin KM, Poncet D, Kroemer G. Chemotherapy: targeting the mitochondrial cell death pathway. Oncogene. 21: 8786-803. PMID 12483532 DOI: 10.1038/Sj.Onc.1206039 |
0.67 |
|
| 2000 |
Bushell M, Poncet D, Marissen WE, Flotow H, Lloyd RE, Clemens MJ, Morley SJ. Cleavage of polypeptide chain initiation factor eIF4GI during apoptosis in lymphoma cells: characterisation of an internal fragment generated by caspase-3-mediated cleavage. Cell Death and Differentiation. 7: 628-36. PMID 10889507 DOI: 10.1038/sj.cdd.4400699 |
0.366 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2016 |
Medves S, Auchter M, Chambeau L, Gazzo S, Poncet D, Grangier B, Verney A, Moussay E, Ammerlaan W, Brisou G, Morjani H, Géli V, Palissot V, Berchem G, Salles G, et al. A high rate of telomeric sister chromatid exchange occurs in chronic lymphocytic leukaemia B-cells. British Journal of Haematology. 174: 57-70. PMID 26970083 DOI: 10.1111/Bjh.13995 |
0.296 |
|
| 2019 |
Bret D, Chappuis V, Poncet D, Ducray F, Silva K, Mion F, Vasiljevic A, Ferraro-Peyret C, Mottolese C, Leblond P, Gabut M, Frappaz D, Streichenberger N, Meyronet D, Bringuier PP, et al. A Multiplex Quantitative Reverse Transcription Polymerase Chain Reaction Assay for the Detection of KIAA1549-BRAF Fusion Transcripts in Formalin-Fixed Paraffin-Embedded Pilocytic Astrocytomas. Molecular Diagnosis & Therapy. PMID 31087282 DOI: 10.1007/S40291-019-00403-3 |
0.294 |
|
| 1989 |
Savatier P, Bagnis C, Thoraval P, Poncet D, Belakebi M, Mallet F, Legras C, Cosset FL, Thomas JL, Chebloune Y. Generation of a helper cell line for packaging avian leukosis virus-based vectors. Journal of Virology. 63: 513-522. PMID 2536089 DOI: 10.1128/Jvi.63.2.513-522.1989 |
0.293 |
|
| 2015 |
Ferrandon S, Malleval C, El Hamdani B, Battiston-Montagne P, Bolbos R, Langlois JB, Manas P, Gryaznov SM, Alphonse G, Honnorat J, Rodriguez-Lafrasse C, Poncet D. Telomerase inhibition improves tumor response to radiotherapy in a murine orthotopic model of human glioblastoma. Molecular Cancer. 14: 134. PMID 26183089 DOI: 10.1186/S12943-015-0376-3 |
0.286 |
|
| 2008 |
Poncet D, Belleville A, t'kint de Roodenbeke C, Roborel de Climens A, Ben Simon E, Merle-Beral H, Callet-Bauchu E, Salles G, Sabatier L, Delic J, Gilson E. Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia. Blood. 111: 2388-91. PMID 18077792 DOI: 10.1182/Blood-2007-09-111245 |
0.284 |
|
| 2019 |
Billard P, Poncet DA. Replication Stress at Telomeric and Mitochondrial DNA: Common Origins and Consequences on Ageing. International Journal of Molecular Sciences. 20. PMID 31597307 DOI: 10.3390/ijms20194959 |
0.281 |
|
| 2011 |
Augereau A, T'kint de Roodenbeke C, Simonet T, Bauwens S, Horard B, Callanan M, Leroux D, Jallades L, Salles G, Gilson E, Poncet D. Telomeric damage in early stage of chronic lymphocytic leukemia correlates with shelterin dysregulation. Blood. 118: 1316-22. PMID 21355086 DOI: 10.1182/Blood-2010-07-295774 |
0.27 |
|
| 2013 |
Ferrandon S, Saultier P, Carras J, Battiston-Montagne P, Alphonse G, Beuve M, Malleval C, Honnorat J, Slatter T, Hung N, Royds J, Rodriguez-Lafrasse C, Poncet D. Telomere profiling: toward glioblastoma personalized medicine. Molecular Neurobiology. 47: 64-76. PMID 23065374 DOI: 10.1007/S12035-012-8363-9 |
0.266 |
|
| 2019 |
Poncet D, Picart T, Guyotat J, Jouanneau E, Joubert B, Vasiljevic A, Honnorat J, Meyronet D, Ducray F, Barritault M. P14.88 Comparison of SNaPshot PCR and digital droplet PCR for the identification of TERT promoter in non-diagnostic biopsies from glioma patients Neuro-Oncology. 21: iii88-iii88. DOI: 10.1093/Neuonc/Noz126.323 |
0.242 |
|
| 2016 |
Wozny AS, Alphonse G, Battiston-Montagne P, Simonet S, Poncet D, Testa E, Guy JB, Rancoule C, Magné N, Beuve M, Rodriguez-Lafrasse C. Influence of Dose Rate on the Cellular Response to Low- and High-LET Radiations. Frontiers in Oncology. 6: 58. PMID 27014633 DOI: 10.3389/Fonc.2016.00058 |
0.24 |
|
| 2019 |
Picart T, Barritault M, Tabouret E, Idbaih A, Izquierdo Gracia C, Poncet D, Honnorat J, Meyronet D, Guyotat J, Ducray F. OS5.5 Characteristics of high-grade gliomas with H3 G34 mutation in adults Neuro-Oncology. 21: iii12-iii12. DOI: 10.1093/Neuonc/Noz126.038 |
0.235 |
|
| 2020 |
Barritault M, Picart T, Poncet D, Fenouil T, d'Hombres A, Gabut M, Guyotat J, Jouanneau E, Ameli R, Joubert B, Streichenberger N, Vasiljevic A, Honnorat J, Meyronet D, Ducray F. Avoiding New Biopsies by Identification of IDH1 and TERT Promoter Mutation in Nondiagnostic Biopsies From Glioma Patients. Neurosurgery. PMID 32107549 DOI: 10.1093/Neuros/Nyaa025 |
0.234 |
|
| 2020 |
Dal Col P, Poncet D, Rivoirard R, Vassal F, Bernichon E, Boutet C, Péoc'h M, Forest F. Acquired ATRX Loss and ALT Phenotype Through Tumor Recurrences in a Case of Pleomorphic Xanthoastrocytoma Suggest Their Possible Roles in Tumor Progression. Journal of Neuropathology and Experimental Neurology. 79: 1011-1014. PMID 32770176 DOI: 10.1093/Jnen/Nlaa074 |
0.232 |
|
| 2017 |
Picart T, Barritault M, Berthillier J, Meyronet D, Vasiljevic A, Frappaz D, Honnorat J, Jouanneau E, Poncet D, Ducray F, Guyotat J. Characteristics of cerebellar glioblastomas in adults. Journal of Neuro-Oncology. PMID 29196927 DOI: 10.1007/S11060-017-2682-7 |
0.23 |
|
| 2018 |
Barritault M, Picart T, Poncet D, Fenouil T, Guyotat J, Jouanneau E, Joubert B, Vasiljevic A, Honnorat J, Meyronet D, Ducray F. PATH-36. IDH AND TERT PROMOTER MUTATIONS IN NON-DIAGNOSTIC BIOPSIES FROM GLIOMA PATIENTS Neuro-Oncology. 20: vi166-vi166. DOI: 10.1093/Neuonc/Noy148.692 |
0.227 |
|
| 2016 |
Bonnin N, Armandy E, Carras J, Ferrandon S, Battiston-Montagne P, Aubry M, Guihard S, Meyronet D, Foy JP, Saintigny P, Ledrappier S, Jung A, Rimokh R, Rodriguez-Lafrasse C, Poncet D. MiR-422a promotes loco-regional recurrence by targeting NT5E/CD73 in head and neck squamous cell carcinoma. Oncotarget. PMID 27281619 DOI: 10.18632/Oncotarget.9829 |
0.223 |
|
| 2014 |
Boyer JC, Etienne-Grimaldi MC, Thomas F, Quaranta S, Picard N, Loriot MA, Poncet D, Gagnieu MC, Ged C, Broly F, Le Morvan V, Bouquié R, Gaub MP, Philibert L, Ghiringhelli F, et al. [Interest of UGT1A1 genotyping within digestive cancers treatment by irinotecan]. Bulletin Du Cancer. 101: 533-53. PMID 24977443 DOI: 10.1684/Bdc.2014.1933 |
0.22 |
|
| 2018 |
Barritault M, Picart T, Poncet D, Fenouil T, Guyotat J, Jouanneau E, Joubert B, Vasiljevic A, Honnorat J, Meyronet D, Ducray F. P01.120 Importance of systematic TERT promoter and IDH mutations screening in non-diagnostic biopsies from patients with a suspected glioma Neuro-Oncology. 20: iii259-iii259. DOI: 10.1093/Neuonc/Noy139.162 |
0.216 |
|
| 2018 |
Izquierdo C, Barritault M, Poncet D, Cartalat S, Joubert B, Bruna J, Jouanneau E, Guyotat J, Vasiljevic A, Fenouil T, Berthezène Y, Honnorat J, Meyronet D, Ducray F. Radiological Characteristics and Natural History of Adult IDH-Wildtype Astrocytomas with TERT Promoter Mutations. Neurosurgery. PMID 30407589 DOI: 10.1093/Neuros/Nyy513 |
0.213 |
|
| 2018 |
Izquierdo C, Barritault M, Poncet D, Cartalat S, Joubert B, Bruna J, Jouanneau E, Guyotat J, Vasiljevic A, Fenouil T, Berthezène Y, Honnorat J, Meyronet D, Ducray F. OS3.3 Radiological characteristics and natural history of adult IDH wild type astrocytomas with TERT promoter mutations Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy139.022 |
0.213 |
|
| 2010 |
Sylvain F, Saultier P, Battiston-Montagne P, Malesys C, Beuve M, Colliaux A, Rodriguez-Lafrasse C, Poncet D. 95: Détermination du statut télomérique comme marqueur prédictif pour l’orientation des patients vers l’hadronthérapie Bulletin Du Cancer. 97: S77-S78. DOI: 10.1016/S0007-4551(15)31188-7 |
0.198 |
|
| 2016 |
Wozny AS, Alphonse G, Battiston-Montagne P, Simonet S, Poncet D, Testa E, Guy JB, Rancoule C, Magné N, Beuve M, Rodriguez-Lafrasse C. Corrigendum: Influence of Dose Rate on the Cellular Response to Low- and High-LET Radiations. Frontiers in Oncology. 6: 271. PMID 28105406 DOI: 10.3389/Fonc.2016.00271 |
0.197 |
|
| 2015 |
Ferrandon S, Magné N, Battiston-Montagne P, Hau-Desbat NH, Diaz O, Beuve M, Constanzo J, Chargari C, Poncet D, Chautard E, Ardail D, Alphonse G, Rodriguez-Lafrasse C. Cellular and molecular portrait of eleven human glioblastoma cell lines under photon and carbon ion irradiation. Cancer Letters. 360: 10-6. PMID 25657111 DOI: 10.1016/j.canlet.2015.01.025 |
0.18 |
|
| 2022 |
Picart T, Poncet D, Barritault M, Bauchet L, Zouaoui S, Guyotat J, Gabut M, Fina F, Honnorat J, Figarella-Branger D, Pallud J, Ducray F, Meyronet D. Molecular Characterization of Adult Tumors Diagnosed as Cerebellar Glioblastomas Identifies Subgroups Associated With Prognosis. The American Journal of Surgical Pathology. 47: 131-144. PMID 36418240 DOI: 10.1097/PAS.0000000000001996 |
0.097 |
|
| 2021 |
Barritault M, Poncet D, Meyronet D, Vasiljevic A, Lopez J, Descotes F, Mottolese C, Basle A, Benoit-Janin M, Pissaloux D, Karanian M, Bringuier PP, Leblond P. NTRK2 gene fusion and resistance mutation: Seventeen-year course of a paediatric glioma. Pediatric Blood & Cancer. e29114. PMID 34003575 DOI: 10.1002/pbc.29114 |
0.088 |
|
| 2021 |
Picart T, Barritault M, Poncet D, Berner LP, Izquierdo C, Tabouret E, Figarella-Branger D, Idbaïh A, Bielle F, Bourg V, Vandenbos FB, Moyal EC, Uro-Coste E, Guyotat J, Honnorat J, et al. Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults. Neuro-Oncology Advances. 3: vdab061. PMID 34056608 DOI: 10.1093/noajnl/vdab061 |
0.061 |
|
| 2023 |
Léonce C, Guerriau C, Chalabreysse L, Duruisseaux M, Couraud S, Brevet M, Bringuier PP, Poncet DA. Comparison and Validation of Rapid Molecular Testing Methods for Theranostic Epidermal Growth Factor Receptor Alterations in Lung Cancer: Idylla versus Digital Droplet PCR. International Journal of Molecular Sciences. 24. PMID 37958668 DOI: 10.3390/ijms242115684 |
0.061 |
|
| 2022 |
Mesny E, Barritault M, Izquierdo C, Poncet D, d'Hombres A, Guyotat J, Jouanneau E, Ameli R, Honnorat J, Meyronet D, Ducray F. Gyriform infiltration as imaging biomarker for molecular glioblastomas. Journal of Neuro-Oncology. PMID 35364762 DOI: 10.1007/s11060-022-03995-9 |
0.058 |
|
| 2011 |
Capraro V, Zane L, Poncet D, Perol D, Galia P, Preudhomme C, Bonnefoy-Berard N, Gilson E, Thomas X, El-Hamri M, Chelghoun Y, Michallet M, Wattel E, Mortreux F, Sibon D. Telomere deregulations possess cytogenetic, phenotype, and prognostic specificities in acute leukemias. Experimental Hematology. 39: 195-202.e2. PMID 21056083 DOI: 10.1016/j.exphem.2010.10.008 |
0.056 |
|
| 2017 |
Lanchon C, Arnoux V, Fiard G, Descotes JL, Rambeaud JJ, Lefrancq JB, Poncet D, Terrier N, Overs C, Franquet Q, Long JA. Super-selective robot-assisted partial nephrectomy using near-infrared flurorescence versus early-unclamping of the renal artery: results of a prospective matched-pair analysis. International Braz J Urol : Official Journal of the Brazilian Society of Urology. 43. PMID 29144626 DOI: 10.1590/S1677-5538.IBJU.2017.0311 |
0.028 |
|
| 2021 |
Long JA, Fiard G, Giai J, Teyssier Y, Fontanell A, Overs C, Poncet D, Descotes JL, Rambeaud JJ, Moreau-Gaudry A, Ittobane T, Bouzit A, Bosson JL, Lanchon C. Superselective Ischemia in Robotic Partial Nephrectomy Does Not Provide Better Long-term Renal Function than Renal Artery Clamping in a Randomized Controlled Trial (EMERALD): Should We Take the Risk? European Urology Focus. PMID 33931361 DOI: 10.1016/j.euf.2021.04.009 |
0.024 |
|
| 2015 |
Lanchon C, Fiard G, Arnoux V, Descotes JL, Rambeaud JJ, Terrier N, Boillot B, Thuillier C, Poncet D, Long JA. High-grade blunt renal trauma: who should we operate? Predictors of surgery and long-term outcome of conservative management, a prospective monocentric study. The Journal of Urology. PMID 26254724 DOI: 10.1016/j.juro.2015.07.100 |
0.022 |
|
| 2018 |
Ghelfi J, Poncet D, Sengel C, Charara S, Delouche A, Guillaume B, Fiard G, Long JA, Ferretti G. Prostatic Fragment Requiring Endoscopic Management After Prostatic Artery Embolization for Indwelling Bladder Catheter. Cardiovascular and Interventional Radiology. PMID 29520430 DOI: 10.1007/s00270-018-1897-0 |
0.012 |
|
| 2015 |
Etienne-Grimaldi MC, Boyer JC, Thomas F, Quaranta S, Picard N, Loriot MA, Narjoz C, Poncet D, Gagnieu MC, Ged C, Broly F, Le Morvan V, Bouquié R, Gaub MP, Philibert L, et al. UGT1A1 genotype and irinotecan therapy: general review and implementation in routine practice. Fundamental & Clinical Pharmacology. 29: 219-37. PMID 25817555 DOI: 10.1111/fcp.12117 |
0.012 |
|
| 2020 |
Franquet Q, Matillon X, Terrier N, Rambeaud JJ, Crouzet S, Long JA, Fassi-Fehri H, Codas-Duarte R, Poncet D, Jouve T, Noble J, Malvezzi P, Rostaing L, Descotes JL, Badet L, et al. The Mayo Adhesive Probability score can help predict intra- and postoperative complications in patients undergoing laparoscopic donor nephrectomy. World Journal of Urology. PMID 33175210 DOI: 10.1007/s00345-020-03513-4 |
0.011 |
|
| 2018 |
Overs C, Teklali Y, Boillot B, Poncet D, Rabattu PY, Robert Y, Piolat C. Evaluation of the Management of Severe Trauma Kidney Injury and Long Term Renal Function in Children. The Journal of Trauma and Acute Care Surgery. PMID 29462089 DOI: 10.1097/TA.0000000000001854 |
0.01 |
|
| Hide low-probability matches. |